The challenges associated with obtaining an optimal pharmaceutical portfolio of projects

Jan. 10, 2012 - PRLog -- SMi presents their 7th annual conference on...
Pharmaceutical Portfolio & Product Lifecycle Management
18th-19th April 2012, The Grange Holborn Hotel, London, United Kingdom

With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry. Lifecycle management approaches must be implemented throughout a products developmental and market period to ensure an increase in profit.  Ultimately, the success of pharmaceutical companies relies on crucial project portfolio decisions and understanding of a product’s lifecycle.

Join SMi at their 7th annual Pharmaceutical Portfolio & Lifecycle Management that will address the challenges associated with obtaining an optimal portfolio of projects. Senior level industry executives will discuss key strategies and management approaches essential to effective portfolio and lifecycle management.

The key speaker line up includes:

Tony Ellery, Managing Director, Ellery Pharma Consulting, Former Global Head LCM in Portfolio Management, Novartis
Kimber Hardy, Head of Valuation and Analysis, Merck Serono
Tim Harris, Director, Respiratory & Immuno-inflammation Portfolio Management, GlaxoSmithKline
Shafique Virani, Global Head CNS Business Development, F. Hoffman La Roche
Sakir Mutevelic, Head of Global Project Management Biopharmaceuticals Hemophilia A/WD, Baxter
Christiano Pereira Silva, Global Product Manager for Pradaxa, Boehringer-Ingelheim
Julie Barrett-Major, Director of Intellectual Property, Norgine
Alan S. Harris, Senior Vice President, Global Projects & Portfolio Management, Ferring Pharmaceuticals
Christine Deuschel, Vice President Portfolio & Project Management, Debiopharm
Anne Lane, Executive Director, University College London Business
Angel Calvo Yague, Healthcare Platform Council Member, Gerson Lehman Group Healthcare & Biomedical Council
Boris Kreye, Lawyer, Bird & Bird
Bruce D Sunstein, Partner, Sunstein Kann Murphy & Timbers LLP
Kerstin Bode-Greuel, Lecturer, University of Essen/PME Institute
Graham Cox, Senior Consultant, IDEA Pharma
Philip Graves, Market Research Consultant, Philip Graves Consultancy
John Ansell, Honorary Consultant, School of Pharmacy and Pharmaceutical Sciences, University of Manchester

For further details and to view a full the conference and list of speakers visit http://www.smi-online.co.uk/pharma-portfolio30.asp